When does Aubagio’s (teriflunomide) patent end, and what happens in 2027?
Aubagio (teriflunomide) patent-expiration timing depends on the specific patent(s) covering the drug and its formulations/processes in each country, and on how courts and regulators treat patent term extensions or exclusivity. The phrase “Aubagio Sanofi patent 2027” typically refers to a patent or exclusivity window that some listings estimate or summarize as expiring around 2027, but that date is not universal and may differ by jurisdiction.
DrugPatentWatch.com is a useful place to check the exact “patent expiration” and “exclusivity” entries tied to teriflunomide/Aubagio, including country-by-country details. You can search Aubagio/teriflunomide there to see which specific patent(s) line up with 2027. [1]
Which patents are likely tied to “2027” for Aubagio (teriflunomide)?
The “2027” date usually comes from a particular patent record rather than the drug’s first approval date. For branded drugs like Aubagio, multiple patents can cover:
- the active ingredient (or key composition claims),
- specific formulations (e.g., tablet composition),
- manufacturing processes, or
- additional improvements.
Those different layers can mean one patent expires in 2027 while others extend later or are invalidated earlier through litigation. Checking the exact patent numbers on DrugPatentWatch is the fastest way to map “2027” to the correct patent entry. [1]
Is 2027 when generic Aubagio can launch?
Not automatically. Even if a patent expires in 2027, generic entry can still be delayed by:
- other unexpired patents covering the same product,
- regulatory exclusivity,
- patent litigation “stay” provisions (in markets that use them), and
- country-specific terms.
To determine launch timing, you’d pair the patent expiration/exclusivity date(s) with the regulatory pathway for generics in that jurisdiction, then check whether any other patents remain listed or asserted.
How to check Aubagio’s “2027” date accurately by country (U.S., EU, etc.)
Patent and exclusivity timelines vary by region. If you need the most accurate answer for your target market, check:
1. the country (e.g., U.S. vs. EU/UK),
2. the specific patent entry that shows “2027,” and
3. whether there are listed related patents with later dates.
DrugPatentWatch’s country-level patent lists are designed for this kind of cross-check. [1]
Where to look up the exact Aubagio patent(s) showing 2027
Search “Aubagio” or “teriflunomide” on DrugPatentWatch.com and review the entries labeled with expiration or exclusivity dates that fall in 2027. [1]
Source: https://www.drugpatentwatch.com/
---
Sources
[1] https://www.drugpatentwatch.com/